DAEHWAN BAE

Dr. DAEHWAN BAE

orcid

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 November 2024 in Acute and Critical Care
Verified
Journal Article
Open access
CPChul Park
Chul Park
NKNam Su Ku
Nam Su Ku
DPDae Won Park
Dae Won Park
JPJoo Hyun Park
Joo Hyun Park
THTae Sun Ha
Tae Sun Ha
SPSunghoon Park
Sunghoon Park
Background: Despite recent advances and global improvements in sepsis recognition and supportive care, mortality rates remain high, and adherence to sepsis bundle components in Korea is low. To address this, the Korean Sepsis Alliance, affiliated with the Korean Society of Critical Care Medicine, developed the first sepsis treatment guidelines for Korea based on a comprehensive systematic review and meta-analysis.Methods: A de novo method was used to develop the guidelines. Methodologies included determining key questions, conducting a literature search and selection, assessing the risk of bias, synthesizing evidence, and developing recommendations. The certainty of evidence and the strength of recommendations were determined using the Grading of Recommendations, Assessment, Development, and Evaluations approach. Draft recommendations underwent internal and external review processes and public hearings. The development of these guidelines was supported by a research grant from the Korean Disease Control and Prevention Agency.Results: In these guidelines, we focused on early treatments for adult patients with sepsis and septic shock. Through the guideline development process, 12 key questions and their respective recommendations were formulated. These include lactate measurement, fluid therapies, target blood pressure, antibiotic administration, use of vasopressors and dobutamine, extracorporeal membrane oxygenation, and echocardiography.Conclusions: These guidelines aim to support medical professionals in making appropriate decisions about treating adult sepsis and septic shock. We hope these guidelines will increase awareness of sepsis and reduce its mortality rate.

1 January 2024 in Korean Circulation Journal
Verified
Journal Article
Open access
MKMin Kim
Min Kim
KHKyoung Hwa Ha
Kyoung Hwa Ha
JLJunyoung Lee
Junyoung Lee
SPSangshin Park
Sangshin Park
KOKyeong Seok Oh
Kyeong Seok Oh
JBJang-Ho Bae
Jang-Ho Bae
Accumulating evidence shows that sodium-glucose cotransporter 2 inhibitors (SGLT2is) reduce adverse cardiovascular outcomes. However, whether SGLT2i, compared with other antidiabetic drugs, reduce the new development of atrial fibrillation (AF) is unclear. In this study, we compared SGLT2i with dipeptidyl peptidase-4 inhibitors (DPP-4is) in terms of reduction in the risk of AF in individuals with type 2 diabetes. We included 42,786 propensity score-matched pairs of SGLT2i and DPP-4i users without previous AF diagnosis using the Korean National Health Insurance Service database between May 1, 2016, and December 31, 2018. During a median follow-up of 1.3 years, SGLT2i users had a lower incidence of AF than DPP-4i users (1.95 vs. 2.65 per 1,000 person-years; hazard ratio [HR], 0.73; 95% confidence interval [CI], 0.55-0.97; p=0.028]). In individuals without heart failure, SGLT2i users was associated with a decreased risk of AF incidence (HR, 0.70; 95% CI 0.52-0.94; p=0.019) compared to DPP-4i users. However, individuals with heart failure, SGLT2i users was not significantly associated with a change in risk (HR, 1.04; 95% CI, 0.44-2.44; p=0.936). In this nationwide cohort study of individuals with type 2 diabetes, treatment with SGLT2i was associated with a lower risk of AF compared with treatment with DPP-4i.

1 January 2025 in Korean Circulation Journal
Verified
Journal Article
Open access
PDF file
HKHyun-Jae Kang
Hyun-Jae Kang
JWJumee Wang
Jumee Wang
ECEun Joo Cho
Eun Joo Cho
HKHack-Lyoung Kim
Hack-Lyoung Kim
CLChan Joo Lee
Chan Joo Lee
PCPolicy Research Institute’ Policy Position Paper Writing Committee
Policy Research Institute’ Policy Position Paper Writing Committee
Kang HJ, et al. Korean Circ J. 2025 Apr;55:e66. https://doi.org/10.4070/kcj.2024.0385

2 July 2024 in Journal of the American Heart Association
Verified
Journal Article
Open access
MBMinjung Bak
Minjung Bak
JYJong-Chan Youn
Jong-Chan Youn
DBDAEHWAN BAE
DAEHWAN BAE
JLJu-Hee Lee
Ju-Hee Lee
SLSunki Lee
Sunki Lee
OIof PPCM registry investigators
of PPCM registry investigators
Background: Although peripartum cardiomyopathy (PPCM) is a fatal disease affecting young patients and fetuses, little is known about its recent prognosis and risk factors. This study investigated temporal trends in clinical characteristics and outcomes for PPCM in a nationwide multicenter registry. Methods and Results: The study population comprised 340 patients (mean age, 33 years) who were diagnosed with PPCM between January 2000 and September 2022 in 26 tertiary hospitals in South Korea. PPCM was defined as heart failure with left ventricular ejection fraction ≤45% and no previously known cardiac disease. The main study outcomes included time to the first occurrence of all‐cause death, heart transplantation, and cardiovascular hospitalization. The diagnosis of PPCM cases increased notably during the study period ( P <0.001). However, clinical outcomes showed no significant improvement (all‐cause death for 10 years: 0.9% [2000–2010] versus 2.3% [2011–2022], P =0.450; all‐cause death and heart transplantation for 10 years: 3.6% [2000–2010] versus 3.0% [2011–2022] P =0.520; all‐cause death, heart transplantation, and cardiovascular hospitalization for 10 years: 11.7% [2000–2010] versus 19.8% [2011–2022], P =0.240). High body mass index (hazard ratio [HR], 1.106 [95% CI, 1.024–1.196]; P =0.011), the presence of gestational diabetes (HR, 5.346 [95% CI, 1.778–16.07]; P =0.002), and increased baseline left ventricular end‐diastolic dimension (HR, 1.078 [95% CI, 1.002–1.159]; P =0.044) were significant risk factors for poor prognosis. Conclusions: While the incidence of PPCM has increased over the past 20 years, the prognosis has not improved significantly. Timely management and close follow‐up are necessary for high‐risk patients with PPCM with high body mass index, gestational diabetes, or large left ventricular end‐diastolic dimension.

1 January 2022 in Journal of Korean Medical Science
Verified
Journal Article
Open access
PDF file
DBDAEHWAN BAE
DAEHWAN BAE
MKMin Kim
Min Kim
DLDae-In LEE
Dae-In LEE
JLJu-Hee Lee
Ju-Hee Lee
SKSangmin Kim
Sangmin Kim
MCMyeong-Chan Cho
Myeong-Chan Cho
Bae DH, et al. J Korean Med Sci. 2022 May;37(21):e169. https://doi.org/10.3346/jkms.2022.37.e169

2 September 2022 in PLOS ONE
Verified
Journal Article
Open access
PDF file
RKRyoung-Eun Ko
Ryoung-Eun Ko
SKSungeun Kim
Sungeun Kim
JLJihye Lee
Jihye Lee
SPSojin Park
Sojin Park
DBDAEHWAN BAE
DAEHWAN BAE
JYJeong Hoon Yang
Jeong Hoon Yang
Background: Limited data are available on clinical phenotype for delirium that occurs frequently among patients admitted to the cardiac intensive care unit (CICU). The objective of this study was to investigate the clinical pictures of delirium, and their association with clinical outcomes in CICU patients. Methods: A total of 4,261 patients who were admitted to the CICU between September 1 2012 to December 31 2018 were retrospectively registered. Patients were excluded if they were admitted to the CICU for less than 24 hours or had missed data. Ultimately, 2,783 patients were included in the analysis. A day of delirium was defined as any day during which at least one CAM-ICU assessment was positive. The clinical risk factors of delirium were classified by the delirium phenotype, as follows; hypoxic, septic, sedative-associated, and metabolic delirium. Results: The incidence of delirium was 24.4% at the index hospitalization in all CICU patients, and 22.6% within 7 days after CICU admission. The most common delirium phenotype was septic delirium (17.2%), followed by hypoxic delirium (16.8%). Multiple phenotypes were observed during most delirium days. Delirium most frequently occurred in patients with heart failure. Of all patients affected by delirium within 7 days, both ICU and hospital mortality significantly increased according to the combined number of delirium phenotypes. Conclusions: Delirium occurred in a quarter of patients admitted to the modern CICU and was associated with increased in-hospital mortality. Therefore, more efforts are needed to reduce the clinical risk factors of delirium, and to prevent it in order to improve clinical outcomes in the CICU.